279 related articles for article (PubMed ID: 37686837)
1. Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review.
Nigro E; D'Agnano V; Quarcio G; Mariniello DF; Bianco A; Daniele A; Perrotta F
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686837
[TBL] [Abstract][Full Text] [Related]
2. Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells
Ter Ellen BM; Niewold J; Flikweert A; Muller Kobold AC; Heeringa P; van Meurs M; Smit JM; van der Voort PHJ; Rodenhuis-Zybert IA; Moser J
Front Immunol; 2022; 13():879033. PubMed ID: 35837388
[TBL] [Abstract][Full Text] [Related]
3. Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study.
Landecho MF; Marin-Oto M; Recalde-Zamacona B; Bilbao I; Frühbeck G
Eur J Intern Med; 2021 Sep; 91():3-9. PubMed ID: 33858724
[TBL] [Abstract][Full Text] [Related]
4. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands.
de Nooijer AH; Kooistra EJ; Grondman I; Janssen NAF; Joosten LAB; van de Veerdonk FL; Kox M; Pickkers P; Netea MG;
Clin Obes; 2023 Apr; 13(2):e12568. PubMed ID: 36426776
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
[TBL] [Abstract][Full Text] [Related]
6. Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
Rajamanickam A; Venkataraman A; Kumar NP; Sasidaran R; Pandiarajan AN; Selvaraj N; Mittal R; Gowshika K; Putlibai S; Lakshan Raj S; Ramanan PV; Babu S
BMC Pediatr; 2023 Apr; 23(1):156. PubMed ID: 37013538
[TBL] [Abstract][Full Text] [Related]
7. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Almerie MQ; Kerrigan DD
Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
[TBL] [Abstract][Full Text] [Related]
8. Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.
Hosoya T; Oba S; Komiya Y; Kawata D; Kamiya M; Iwai H; Miyamoto S; Kataoka M; Tobiume M; Kanno T; Ainai A; Sato H; Hirakawa A; Mitsui Y; Satoh T; Wakabayashi K; Yamada T; Otomo Y; Miyazaki Y; Hasegawa H; Suzuki T; Yasuda S
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2300155120. PubMed ID: 37216518
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines in obesity and metabolic disease.
Cao H
J Endocrinol; 2014 Feb; 220(2):T47-59. PubMed ID: 24403378
[TBL] [Abstract][Full Text] [Related]
10. Immunological and Hematological Response in COVID-19.
Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.
Michalakis K; Ilias I
Diabetes Metab Syndr; 2020; 14(4):469-471. PubMed ID: 32387864
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Obesity: Overlapping of Two Pandemics.
Gammone MA; D'Orazio N
Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546
[TBL] [Abstract][Full Text] [Related]
13. Circulating adipokine levels and COVID-19 severity in hospitalized patients.
Flikweert AW; Kobold ACM; van der Sar-van der Brugge S; Heeringa P; Rodenhuis-Zybert IA; Bijzet J; Tami A; van der Gun BTF; Wold KI; Huckriede A; Franke H; Emmen JMA; Emous M; Grootenboers MJJH; van Meurs M; van der Voort PHJ; Moser J
Int J Obes (Lond); 2023 Feb; 47(2):126-137. PubMed ID: 36509969
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
Hulme KD; Noye EC; Short KR; Labzin LI
Front Immunol; 2021; 12():770066. PubMed ID: 34777390
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.
Maurya R; Sebastian P; Namdeo M; Devender M; Gertler A
Front Immunol; 2021; 12():649359. PubMed ID: 34220807
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.
Vasheghani M; Hessami Z; Rekabi M; Abedini A; Qanavati A
Obes Surg; 2022 May; 32(5):1689-1700. PubMed ID: 35113309
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of the obese population to COVID-19.
Kimura T; Namkoong H
Int J Infect Dis; 2020 Dec; 101():380-381. PubMed ID: 33045426
[TBL] [Abstract][Full Text] [Related]
18. Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.
Behl T; Kumar S; Singh S; Bhatia S; Albarrati A; Albratty M; Meraya AM; Najmi A; Bungau S
Biomed Pharmacother; 2022 Jul; 151():113178. PubMed ID: 35644117
[TBL] [Abstract][Full Text] [Related]
19. Obesity, Nutrients and the Immune System in the Era of COVID-19.
De Bandt JP; Monin C
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33668493
[TBL] [Abstract][Full Text] [Related]
20. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
